JAFIB-EP serves the needs of a diverse global EP community. The Journal provides a forum for communicating original and innovative research findings that have relevance and a deeper understanding of the pathophysiology of cardiac rhythm disorders to improve the treatment, quality of life and survival of millions of patients across the globe.

JAFIB-EP is brought to life by a committed board of clinical scientists and academics to bridge the digital and economic divide in sharing knowledge and science around the world.

JAFIB-EP articles cover the breadth of EP conditions. These include Atrial Fibrillation (AF), Ventricular Arrhythmias (VA) and conduction system abnormalities that contribute to significant patient morbidity and mortality, through stroke, heart failure, sudden cardiac arrest and more. EP is a dynamic field that, with continued discovery and innovation, has helped bring many therapies from bench to bedside for clinical application to patients.

JAFIB-EP offers a free publication platform. Publication and access to the EP and related fields of science has become dramatically expensive. While the digital revolution has leveled the playing field in other arenas, it has broadened the gap in the medical publishing space.